Hepatocellular carcinoma: is surveillance cost effective?

Affiliations

Comment

J Bruix et al. Gut. 2001 Feb.

. 2001 Feb;48(2):149-50.

doi: 10.1136/gut.48.2.149.

¹ BCLC Group, Liver Unit, Hospital Clínic IDIBAPS, University of Barcelona, Catalonia, Spain. jbruix@clinic.ub.es

No abstract available

Comment in

Surveillance for hepatocellular carcinoma in liver cirrhosis: have programmes improved because patients have?
Giannini E, Testa R. Giannini E, et al. Gut. 2002 Sep;51(3):456-7. doi: 10.1136/gut.51.3.456-a. Gut. 2002. PMID: 12171975 Free PMC article. No abstract available.
Surveillance for hepatocellular carcinoma in liver cirrhosis: have programmes improved because patients have?
Giannini E, Testa R. Giannini E, et al. Gut. 2002 Oct;51(4):611. doi: 10.1136/gut.51.4.611. Gut. 2002. PMID: 12235093 Free PMC article. No abstract available.

Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis.
Bolondi L, Sofia S, Siringo S, Gaiani S, Casali A, Zironi G, Piscaglia F, Gramantieri L, Zanetti M, Sherman M. Bolondi L, et al. Gut. 2001 Feb;48(2):251-9. doi: 10.1136/gut.48.2.251. Gut. 2001. PMID: 11156649 Free PMC article.